uspto-grants-2016_01 · 10.6084/m9.figshare.5104873.v1 · US09238655B2
查看HCID86684366
(4-(4-Methyl-6-(6-(4-(oxetan-3-yl)piperazin-1-yl)pyridin-3-ylamino)-5-oxo-4,5-dihydropyrazin-2-yl)-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2(1H)-yl)pyridin-3-yl)methyl Acetate
[4-[4-methyl-6-[[6-[4-(oxetan-3-yl)piperazin-1-yl]-3-pyridinyl]amino]-5-oxopyrazin-2-yl]-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2-yl)-3-pyridinyl]methyl acetate
C36H41N9O5679.8 g/mol
IDENTITY
结构与身份
- 标准SMILES
- CC(=O)OCc1c(-c2cn(C)c(=O)c(Nc3ccc(N4CCN(C5COC5)CC4)nc3)n2)ccnc1N1CCn2c(cc3c2CCCC3)C1=O
- InChIKey
- SASUHHGCYIUTDA-UHFFFAOYSA-N
- 分子式
- C36H41N9O5
- 平均分子量
- 679.8 g/mol
- 单同位素质量
- 679.32306544
COMPUTED
结构计算性质
- XLogP
- 1.4
- 极性表面积
- 138 Ų
- 氢键供体
- 1
- 氢键受体
- 10
- 可旋转键
- 9
- 重原子
- 50
- 形式电荷
- 0
- 复杂度
- 1,350
ALIASES
名称与别名
SCHEMBL14930385SCHEMBL29742167SASUHHGCYIUTDA-UHFFFAOYSA-N(4-(4-Methyl-6-(6-(4-(oxetan-3-yl)piperazin-1-yl)pyridin-3-ylamino)-5-oxo-4,5-dihydropyrazin-2-yl)-2-(1-oxo-3,4,6,7,8,9-hexahydropyrazino[1,2-a]indol-2(1H)-yl)pyridin-3-yl)methyl Acetate
REACTIONS
参与反应
uspto-grants-2016_01 · 10.6084/m9.figshare.5104873.v1 · US09238655B2
查看uspto-grants-2014_05 · 10.6084/m9.figshare.5104873.v1 · US08716274B2
查看uspto-grants-2014_05 · 10.6084/m9.figshare.5104873.v1 · US08716274B2
查看uspto-grants-2014_12 · 10.6084/m9.figshare.5104873.v1 · US08921353B2
查看uspto-grants-2014_12 · 10.6084/m9.figshare.5104873.v1 · US08921353B2
查看